Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Objective Resistance to antibiotics is the major cause of treatment failure of Helicobacter
pylori infection. A study was conducted to assess prospectively the antibacterial resistance …

H. pylori is one of the most common bacterial infections in human beings, and its discovery
20 years ago altered the diagnosis and treatment of gastroduodenal disease. This review …

Peptic ulcer disease had a tremendous effect on morbidity and mortality until the last
decades of the 20th century, when epidemiological trends started to point to an impressive …

Triple therapy, including two antibiotics, amoxicillin and clarithromycin, and a proton pump
inhibitor given for a week has been recommended as the treatment of choice at several …

Significant progress and new insights have been gained in the 4 years since the first
Maastricht Consensus Report, necessitating an update of the original guidelines. To achieve …

Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

Background: Over the past few years, the profile of Helicobacter pylori infection has changed
in Japan. In particular, the relationship between H. pylori and gastric cancer has been …

Background Information regarding the effects of drug resistance on therapies for
Helicobacter pylori is limited. Aims To determine the effect of drug resistance on the efficacy …